Physician
DR Ye's Medical Office, P.C.
DR Ye's Medical Office, P.C. was paid $11.06M by Medicaid between Jan 2018 and Nov 2024, across 112 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.
33Billing provider infoDR YE'S MEDICAL OFFICE, P.C.
BROOKLYN, NY 11220
BROOKLYN, NY 11220
33aNPI1528222577assigned 07/17/2008
33bProvider typeFamily Medicine Physician
28Total paid$11.06M
24GClaims416,549
24DCodes billed112
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#12 of 2,605
Median peer was paid$10K
This provider vs. median1,095×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,024 | $1.08M | |
| 2019 | 61,039 | $1.41M | |
| 2020 | 55,960 | $1.44M | |
| 2021 | 86,930 | $2.40M | |
| 2022 | 81,051 | $2.31M | |
| 2023 | 38,769 | $1.17M | |
| 2024incomplete | 52,776 | $1.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 57% | 72,286 | 51,432 | $6.36M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.5% | 5,575 | 5,412 | $714K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.9% | 11,963 | 11,062 | $648K |
| 90651 | 5.5% | 2,387 | 2,384 | $607K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.5% | 4,230 | 4,184 | $503K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.9% | 3,326 | 3,210 | $435K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.9% | 12,341 | 11,950 | $214K |
| 90750 | 1.3% | 753 | 753 | $149K | |
| 90674 | 1.1% | 4,348 | 4,345 | $126K | |
| H0049 | Alcohol and/or drug screening | 1.1% | 12,002 | 11,943 | $122K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 856 | 856 | $98K |
| 87428 | <1% | 1,514 | 1,348 | $75K |
100 more codes
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 13,116 | $72K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 11,909 | $71K |
| 83013 | <1% | 1,097 | $70K | |
| 99442 | <1% | 865 | $69K | |
| 3074F | <1% | 32,410 | $62K | |
| 3078F | <1% | 30,927 | $59K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,613 | $57K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,012 | $53K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,660 | $47K |
| 99050 | <1% | 13,231 | $44K | |
| 90715 | <1% | 1,027 | $38K | |
| 82274 | <1% | 2,261 | $32K | |
| 90686 | <1% | 2,195 | $32K | |
| 0011A | <1% | 628 | $26K | |
| 0012A | <1% | 615 | $26K | |
| 93000 | <1% | 2,570 | $26K | |
| 90688 | <1% | 1,254 | $23K | |
| 90679 | <1% | 55 | $17K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 120 | $15K |
| 90732 | <1% | 95 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,556 | $12K |
| 3079F | <1% | 5,141 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 487 | $11K |
| 90661 | <1% | 317 | $10K | |
| 0064A | <1% | 621 | $10K | |
| 99406 | <1% | 1,164 | $9K | |
| 83014 | <1% | 1,133 | $8K | |
| 0003A | <1% | 195 | $8K | |
| 3075F | <1% | 3,639 | $8K | |
| 36410 | <1% | 2,436 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 70 | $7K |
| 97802 | <1% | 5,044 | $6K | |
| 98927 | <1% | 88 | $5K | |
| 91320 | <1% | 45 | $5K | |
| 99497 | <1% | 77 | $5K | |
| 90746 | <1% | 75 | $4K | |
| 99401 | <1% | 251 | $4K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 96 | $3K |
| 3080F | <1% | 904 | $3K | |
| 3077F | <1% | 894 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,394 | $2K |
| 90656 | <1% | 104 | $2K | |
| 0013A | <1% | 48 | $2K | |
| 90620 | <1% | 73 | $2K | |
| 90672 | <1% | 231 | $1K | |
| 90480 | <1% | 43 | $1K | |
| 0134A | <1% | 43 | $1K | |
| 96160 | <1% | 207 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 115 | $1K |
| 90632 | <1% | 18 | $1K | |
| 0513F | <1% | 1,090 | $1K | |
| 90461 | <1% | 63 | $956.21 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 55 | $915.65 |
| 81003 | <1% | 538 | $813.21 | |
| 0124A | <1% | 23 | $737.71 | |
| 86580 | <1% | 89 | $718.60 | |
| 90658 | <1% | 43 | $712.99 | |
| 99408 | <1% | 9,540 | $638.12 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,527 | $480.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 37 | $391.03 |
| 3066F | <1% | 646 | $260.00 | |
| 0071A | <1% | 38 | $120.00 | |
| 3044F | <1% | 124 | $120.00 | |
| 96127 | <1% | 1,167 | $90.73 | |
| 99072 | <1% | 6,243 | $88.00 | |
| 3061F | <1% | 342 | $72.00 | |
| 0072A | <1% | 57 | $40.00 | |
| 99000 | <1% | 21,994 | $20.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | $14.54 |
| 3008F | <1% | 39,029 | $3.44 | |
| 91301 | <1% | 1,914 | $3.23 | |
| 91300 | <1% | 533 | $0.05 | |
| 91312 | <1% | 23 | $0.01 | |
| G9276 | Documentation that patient is a current tobacco user | 0% | 543 | $0.00 |
| 90734 | 0% | 72 | $0.00 | |
| 3725F | 0% | 8,279 | $0.00 | |
| 91313 | 0% | 41 | $0.00 | |
| 1032F | 0% | 199 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 65 | $0.00 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 1,505 | $0.00 |
| 1159F | 0% | 18 | $0.00 | |
| 4040F | 0% | 12 | $0.00 | |
| 0002A | 0% | 128 | $0.00 | |
| 3016F | 0% | 536 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 79 | $0.00 |
| 1160F | 0% | 18 | $0.00 | |
| 1158F | 0% | 18 | $0.00 | |
| 1000F | 0% | 5,936 | $0.00 | |
| 1036F | 0% | 5,452 | $0.00 | |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 8,425 | $0.00 |
| 4010F | 0% | 670 | $0.00 | |
| 3017F | 0% | 1,295 | $0.00 | |
| 4000F | 0% | 169 | $0.00 | |
| H0001 | Alcohol and/or drug assessment | 0% | 829 | $0.00 |
| 1125F | 0% | 16 | $0.00 | |
| 3048F | 0% | 119 | $0.00 | |
| 0001A | 0% | 106 | $0.00 | |
| 1157F | 0% | 18 | $0.00 | |
| 91307 | 0% | 105 | $0.00 | |
| 1170F | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYE, HONG (DIRECTOR)